NCT05996419

Brief Summary

Social anxiety is associated with significant deficits in social and occupational functioning. The proposed study seeks to evaluate the feasibility of implementing a brief text-based intervention for decreasing social anxiety related safety behaviors among Veterans attempting to re-integrate into the workforce. Findings from this pilot will support a larger randomized controlled study examining the efficacy of the intervention for improving functional outcomes and quality of life among Veterans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

1.4 years

First QC Date

August 9, 2023

Last Update Submit

January 26, 2026

Conditions

Keywords

VeteranSocial Anxietyworkforce

Outcome Measures

Primary Outcomes (2)

  • Subtle Avoidance Frequency Examination (SAFE)

    32-item self-report measure designed to assess the frequency of safety behavior (SB) use. Respondents are asked to rate how often they engage in SBs such as "Rehearse sentences in your mind" and "Avoid eye contact" on a scale of 0 (Never) to 4 (Always). Scores on the SAFE range from 0-128 with higher scores indicative or more safety behavior use. total mean score

    Baseline and immediately after intervention

  • Social Phobia Inventory (SPIN)

    17-item measure of social anxiety severity. Participants are asked to rate items such as "I avoid doing things or speaking to people for fear of embarrassment" on a Likert-type scale of 0 (Not at all) to 4 (Extremely). Scores on the SPIN range from 0 to 68 with higher scores indicative of more severe social anxiety, total mean score

    baseline and immediately after intervention

Other Outcomes (9)

  • General Self-Efficacy Scale (GSE)

    Baseline and immediately after intervention

  • PTSD Checklist (PCL-5)

    Baseline and immediately after intervention

  • Patient Health Questionnaire (PHQ-9)

    Baseline and immediately after intervention

  • +6 more other outcomes

Study Arms (1)

DSB-Intervention

EXPERIMENTAL

Active intervention group receives text message intervention via ANNIE for 30 days

Other: DSB-I

Interventions

DSB-IOTHER

Participant will receive text message every other day during active phase (30days) via ANNIE text messaging app related to the safety behaviors they identified prior to start.

DSB-Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Active enrollment in Compensated Work Therapy
  • Score of \> 25 on the Social Phobia Inventory
  • Score of \> 47 on the Subtle Avoidance Frequency Examination

You may not qualify if:

  • Concurrent enrollment in another study related to social anxiety or improving functional status
  • Recent (\<3 month) history of psychiatric hospitalization, detoxification admission, or suicide attempt

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, 29401-5703, United States

Location

Study Officials

  • Anouk L. Grubaugh, PhD MA BS

    Ralph H. Johnson VA Medical Center, Charleston, SC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: open trial
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2023

First Posted

August 18, 2023

Study Start

July 1, 2024

Primary Completion

November 28, 2025

Study Completion

December 31, 2025

Last Updated

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations